Dexamethasone/Pancreatic Clamp P & F
Conditions: Insulin Resistance; Prediabetic State; Non-Alcoholic Fatty Liver Disease; Overweight and Obesity Interventions: Drug: Insulin human; Drug: Octreotide Acetate; Drug: Glucagon; Drug: Human Growth Hormone; Drug: Dexamethasone Oral; Other: [6,6-2H2] D-glucose; Drug: 20% D-glucose (aq); Dietary Supplement: BOOST Plus; Device: Harvard Apparatus PHD ULTRA CP syringe pump; Device: Yellow Springs Instruments (YSI) 2500 Biochemistry Glucose/Lactate Analyzer; Other: Normal saline; Other: Human albumin Sponsors: Columbia University; Albert Einstein College of Medicine; National Institute of Diabetes and Digestive and Kidne...
Source: - November 10, 2023 Category: Research Source Type: clinical trials

Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction
Conditions: Heart Failure With Preserved Ejection Fraction; Obesity, Mild; Decompensated Heart Failure Interventions: Diagnostic Test: Echocardiography; Diagnostic Test: Bioimpedance; Diagnostic Test: Immunoassay; Diagnostic Test: Routine biochemistry Sponsors: National Medical Research Center for Therapy and Preventive Medicine; Moscow State Clinical Hospital named after V.V. Veresaev Recruiting (Source:
Source: - November 2, 2023 Category: Research Source Type: clinical trials

Proof of Concept Open Label, Clinical Trial to Evaluate the Safety and Efficacy of the " FITT " Device in Diabetic Foot Ulcers Patients
Condition:   Diabetic Foot Ulcer Interventions:   Device: Study treatment administration (TriO FITT);   Diagnostic Test: Physical Examination;   Diagnostic Test: Vital Signs;   Diagnostic Test: Hematology Blood Tests;   Diagnostic Test: Biochemistry Blood Test;   Diagnostic Test: Wound Digital Photography;   Diagnostic  Test: Urine pregnancy test;   Other: Numeric Pain Rating Scale;   Other: Visual Analogue Scale;   Other: SF-36;   Diagnostic Test: Wounds evaluation Sponsor:   Tri.O Medical LTD Recruiting (Source:
Source: - August 22, 2023 Category: Research Source Type: clinical trials

Fenofibrate in Ulcerative Colitis
Condition:   Inflammatory Bowel Diseases Interventions:   Drug: Mesalamine;   Drug: Fenofibrate 160mg Sponsors:   Tanta University;   Eman Ibrahim Elberri, Clinical Pharmacy Department, Faculty of Pharmacy, Tanta University;   Hend El-Said Abo Mansour, Biochemistry Department, Faculty of Pharmacy, Menoufia University;   Monir Hussein Bahgat, Internal Medicine Department (Gastroenterology and Hepatology) , Faculty of Medicine, Mansura University;   Eman Maamoun Ali El-Khateeb, Lecturer of Clinical Pharmacy, Clinical Pharmacy Department, Faculty of Pharmacy, Tanta University Recruiting (Source:
Source: - March 3, 2023 Category: Research Source Type: clinical trials